Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azfar Zaman

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 2021
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb ConsortiumJens Wiebe, Felix J Hofmann, Nick West, et al.
Journal of the American Heart Association|July 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI TrialRobert F Storey, John Deanfield, Stefan James, et al.
JACC. Cardiovascular Interventions|November 10, 2018
Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel DiseaseTaku Asano, Yuki Katagiri, Chun Chin Chang, et al.
Interventional Cardiology (London, England)|March 14, 2025
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention SocietyNick Curzen, Helen Routledge, Samuel McGrath, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 1, 2025
Clinical outcomes of the BioMime™ morph coronary stent system for long (30 to ≤56 mm length) coronary lesions: Three-year follow-up of the Morpheus Global RegistryPierfrancesco Agostoni, Jan-Peter Van Kuijk, Paul Knaapen, et al.
European Journal of Heart Failure|December 18, 2024
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial dataOffer Amir, Gabby Elbaz-Greener, Shemy Carasso, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 20, 2019
Impact of established cardiovascular disease on outcomes in the randomized global leaders trialScot Garg, Ply Chichareon, Norihiro Kogame, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Circulation. Cardiovascular Interventions|November 10, 2020
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk PatientsDavid E Kandzari, Ajay J Kirtane, Stephan Windecker, et al.
Scientific Reports|January 14, 2018
FDXR is a biomarker of radiation exposure in vivoGráinne O'Brien, Lourdes Cruz-Garcia, Matthäus Majewski, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 31, 2021
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb ConsortiumJens Wiebe, Felix J Hofmann, Nick West, et al.
Journal of the American Heart Association|July 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI TrialRobert F Storey, John Deanfield, Stefan James, et al.
JACC. Cardiovascular Interventions|November 10, 2018
Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel DiseaseTaku Asano, Yuki Katagiri, Chun Chin Chang, et al.
Interventional Cardiology (London, England)|March 14, 2025
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention SocietyNick Curzen, Helen Routledge, Samuel McGrath, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 1, 2025
Clinical outcomes of the BioMime™ morph coronary stent system for long (30 to ≤56 mm length) coronary lesions: Three-year follow-up of the Morpheus Global RegistryPierfrancesco Agostoni, Jan-Peter Van Kuijk, Paul Knaapen, et al.
European Journal of Heart Failure|December 18, 2024
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial dataOffer Amir, Gabby Elbaz-Greener, Shemy Carasso, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 20, 2019
Impact of established cardiovascular disease on outcomes in the randomized global leaders trialScot Garg, Ply Chichareon, Norihiro Kogame, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Circulation. Cardiovascular Interventions|November 10, 2020
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk PatientsDavid E Kandzari, Ajay J Kirtane, Stephan Windecker, et al.
Scientific Reports|January 14, 2018
FDXR is a biomarker of radiation exposure in vivoGráinne O'Brien, Lourdes Cruz-Garcia, Matthäus Majewski, et al.
Pageof 15